Trehalose is a disaccharide of glucose, and is known to be potentially useful 
for the treatment of HD (Huntington's Disease), because it blocks the poly 
Q (glutamine) aggregation,  the major cause of HD.  Interestingly, like 
the heat-shock protein gene (HSP16), trehalose 6-phosphate synthase (TPS-1 
and TPS-2) genes are activated by the longevity transcription factor FOXO. 
Recently Honda' s group at Gerontology Institute in Tokyo discovered that 
trehalose extends the longevity of C. elegans by 60% even if its treatment 
started at an old adult stage. This finding is very encouraging for those 
who have already reached 60!  
More interestingly, trehalose increases the thermo-tolerance which dependents 
on heat shock proteins such as Hsp16. This finding suggests the possibility 
that trehalose activates Hsp16 gene, through FOXO, somehow.  We and others 
found recently that FOXO is activated by several signaling pathways including 
SIRT1/LKB1/AMPK, and the tumor suppressor PTEN which inactivates both oncogenic
 kinases AKT and PAK1. 
Does trehalose suppress  the growth of cancers?  Yes, almost two decades 
ago, a Canadian group reported that, like sodium butylate,  trehalose blocks 
the malignant growth of human colon (RAS-transformed) cancer cells and 
re-differentiates them into normal cells. Since sodium butylate, a HDAC 
inhibitor, up-regulates PTEN, inactivating both AKT and PAK1, it is possible 
that  trehaloase also up-regulates PTEN, eventually activating FOXO and Hsp16 gene.

0 件のコメント:
コメントを投稿